ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/07/26
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 07/31/26
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ETGlobeNewsWire • 07/24/26
Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supplyCNBC • 07/22/26
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious UveitisGlobeNewsWire • 07/13/26
ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin SurgeThe Motley Fool • 07/09/26
Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-TermZacks Investment Research • 05/29/26
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/27/26
ANI Pharmaceuticals (ANIP) is a Top-Ranked Momentum Stock: Should You Buy?Zacks Investment Research • 05/13/26